Ryan Maynard

Ryan Maynard

Finansdirektör/CFO på FOGHORN THERAPEUTICS INC.
56 år
Health Technology
Technology Services
Electronic Technology

Profil

Ryan D.
Maynard
is currently an Independent Director at Iovance Biotherapeutics, Inc. since 2015 and Chief Financial & Accounting Officer at Foghorn Therapeutics, Inc. starting in 2026.
Former roles include Chief Financial Officer at CARA Therapeutics, Inc. from 2022 to 2025; Chief Financial Officer at LetsGetChecked, Inc. from 2019 to 2022; Chief Financial Officer at Blade Therapeutics, Inc. from 2018 to 2019; CFO, Executive VP & Head-Investor Relations at Rigel Pharmaceuticals, Inc. from 2011 to 2017; Controller, Director-Finance & Accounting at Personify, Inc. (California) in 2001; Controller at General Magic, Inc. from 1998 to 1999; Senior Manager-Finance at Siliconix, Inc. from 1994 to 1998; and Chief Financial Officer at Paulus.
(Holdings) Ltd. Education includes undergraduate studies at Santa Clara University.

Aktiva positioner av Ryan Maynard

FöretagPositionStart
IOVANCE BIOTHERAPEUTICS, INC. Direktör/Styrelseledamot 2015-02-16
FOGHORN THERAPEUTICS INC. Finansdirektör/CFO 2026-02-23

Tidigare kända positioner av Ryan Maynard

FöretagPositionSlut
CARA THERAPEUTICS, INC. Finansdirektör/CFO 2025-04-01
Finansdirektör/CFO 2022-03-01
Finansdirektör/CFO 2019-06-01
RIGEL PHARMACEUTICALS, INC. Finansdirektör/CFO 2017-12-31
Finansdirektör/CFO 2001-04-01
Se detaljerna i Ryan Maynards erfarenhet

Ryan Maynards utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

51

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Electronic Technology

Technology Services

Health Technology

Technology Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Technology Services

Finance

  1. Börsen
  2. Insiders
  3. Ryan Maynard
SENASTE TIDEN | -40%: De bästa verktygen för prenumeranter för att identifiera morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU